Cargando…
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
BACKGROUND: Breast cancer currently is the most frequently diagnosed neoplasm and the leading cause of death from cancer in women worldwide, which is mainly due to metastatic disease. Increasing our understanding of the molecular mechanisms leading to metastasis might thus improve the pharmacologica...
Autores principales: | Esparza-López, José, Alvarado-Muñoz, Juan Francisco, Escobar-Arriaga, Elizabeth, Ulloa-Aguirre, Alfredo, de Jesús Ibarra-Sánchez, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651945/ https://www.ncbi.nlm.nih.gov/pubmed/31337349 http://dx.doi.org/10.1186/s12885-019-5945-1 |
Ejemplares similares
-
Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells
por: Esparza-López, José, et al.
Publicado: (2022) -
NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype
por: Oh, Amy, et al.
Publicado: (2023) -
P990: NF-ΚB AND JAK/STAT PATHWAYS INHIBITION REVERSES FIBROSIS IN A MURINE MODEL OF INFLAMMATION-DRIVEN MYELOFIBROSIS
por: Zamora, Ernesto José Cuenca, et al.
Publicado: (2023) -
NF-κB, Mesenchymal Differentiation and Glioblastoma
por: Yamini, Bakhtiar
Publicado: (2018) -
STAT3/NF-κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF-κB signaling pathway in a mouse model of atherosclerosis
por: An, Hyun-Jin, et al.
Publicado: (2023)